Autopsy report · NCT03531125

Gene Expression in Pancreatic Cancer

“Study was closed early due to low numbers of evaluable patients”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 1 year 8 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

University of Oxford

Sponsor type

University, hospital or other

Conditions

Pancreatic Cancer

Interventions

Endoscopic Ultrasound; Pancreaticoduodenectomy

Participants

9

Sites

1

Countries

United Kingdom

Trials that died the same way

• Reiki for the Management of Neuropathic Pain
  “Study closed due to substantial decrease in the desired patient population.” (74% match in meaning)
• A Study of Alectinib in RET-rearranged Non-small Cell Lung Cancer or RET-mutated Thyroid Cancer
  “Study closed due to slow accrual and lack of efficacy.” (67% match in meaning)
• Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery
  “The study was stopped due to difficulties in including patients” (67% match in meaning)
• Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting
  “Study closed before patients enrolled” (65% match in meaning)
• Xenogenic Keratoplasty From Porcine Cornea
  “there was not enough patients recruited in this study” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.